Endo Health Solutions Inc. (ENDP) is in talks with drug makers about selling itself, Reuters reported, citing people familiar with the matter.

Shares were recently 9% higher at $31.23 after tripping a single-stock circuit breaker. The stock is down 13% over the last 12 months.

The exploratory talks include Warner Chilcott PLC (WCRX) and Valeant Pharmaceuticals International Inc. (VRX, VRX.T), but there is no official auction process underway and discussions are at a preliminary stage, according to the report.

A representative for Endo declined to comment to Dow Jones, while Warner Chilcott and Valeant didn't immediately respond to requests for comment.

Earlier this month, Endo Health lowered its 2013 guidance, saying it expects higher charges related to its core painkiller franchise and generic-drug business.

Full story: http://www.reuters.com/article/2013/01/30/us-endohealth-sale-idUSBRE90T19020130130

Write to Hot Stocks at hotstocks@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


Endo (NASDAQ:ENDP)
Historical Stock Chart
From May 2020 to May 2020 Click Here for more Endo Charts.
Endo (NASDAQ:ENDP)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Endo Charts.